BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...
Companies developing 505(b)(2), NDA, ANDA, branded or generic prescription drug products are encouraged to explore LGM Pharma’s expanded manufacturing capabilities by visiting LGMPharma.com or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback